We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ticker | Name | Price | Change | Change % | Volume | Trades |
---|---|---|---|---|---|---|
VSRO | Voltaic Strategic Resources Ltd | 0.006 | 0.003 | 100.00% | 100,000 | 2 |
NOROD | Norwood Systems Limited | 0.019 | 0.009 | 90.00% | 100,000 | 1 |
H2G | GreenHy2 Ltd | 0.01 | 0.004 | 66.67% | 1,273,876 | 4 |
SRK | Strike Resources Limited | 0.071 | 0.027 | 61.36% | 8,938,223 | 197 |
RFT | Rectifier Technologies Ltd | 0.014 | 0.005 | 55.56% | 7,413,216 | 51 |
VTXOA | Vertex Minerals Ltd | 0.015 | 0.005 | 50.00% | 83,334 | 1 |
KNBO | Koonenberry gold Ltd | 0.006 | 0.002 | 50.00% | 71,430 | 1 |
M2MO | MT Malcolm Mines NL | 0.003 | 0.001 | 50.00% | 800,000 | 3 |
CAIOA | Calidus Resources Limited | 0.006 | 0.002 | 50.00% | 443,094 | 5 |
YPB | YPB Group Ltd | 0.003 | 0.001 | 50.00% | 1,000,082 | 4 |
SNS | SenSen Networks Limited | 0.03 | 0.008 | 36.36% | 819,153 | 35 |
TORONTO and GLIL YAM, Israel, May 1, 2024 /PRNewswire/ --Â IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the first quarter 2024 ended March 31, 2024, on Wednesday, May 8, 2024, before the market opens.
ANDOVER, Mass., April 30, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today reported financial results for the quarter ended March 31, 2024.
CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced it will report financial results for the first quarter 2024 after market close on Thursday, May 9, 2024. Company management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today reported financial results for its second quarter ended March 31, 2024, and updated financial guidance for its fiscal year ending September 30, 2024.
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 57,247.85 | -3,352.86 | -5.53% | 1.12T | 7,878,391,028 |
ETH | Ethereum | 2,894.45 | -116.36 | -3.86% | 346.94B | 3,366,849,355 |
USDT | Tether USD | 0.99896 | -0.00019 | -0.02% | 97.74B | 460,599,273 |
BNB | Binance Coin | 549.57 | -28.01 | -4.85% | 86.53B | 526,711,944 |
SOL | Solana | 123.37 | -3.32 | -2.62% | 54.37B | 1,440,153,391 |
STETH | stETH | 2,881.51 | -127.19 | -4.23% | 28.28B | 14,346,542 |
USDC | USD Coin | 1.00 | 0.0001 | 0.01% | 28.07B | 1,177,859,036 |
XRP | Ripple | 0.4959 | -0.0038 | -0.76% | 27.03B | 372,326,841 |
DOGE | Dogecoin | 0.12378 | -0.00935 | -7.02% | 17.74B | 531,957,147 |
TONCOIN | Wrapped TON Coin | 4.74 | -0.426982 | -8.27% | 16.4B | 128,935,815 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions